SLT Holdings’s Astera Labs ALAB Stock Holding History

SLT Holdings’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-750	Closed	-$362K	–	192
2026 Q2	$362K	Buy	+750	New	+$199K	0.22%	94

Other funds holding ALAB

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SLT Holdings's ALAB Position: Q3 2026 in Review

SLT Holdings sold out of Astera Labs (ALAB) in Q3 2026, closing a stake of 750 shares — an estimated $362K sold.

SLT Holdings first reported a position in ALAB in Q2 2026 and held it in 1 quarter. The position peaked at $362K in Q2 2026. 519 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

SLT Holdings reported no remaining Astera Labs position as of Q3 2026 after selling out during the quarter.
SLT Holdings sold 750 Astera Labs shares in Q3 2026, an estimated $362K.
SLT Holdings first reported a position in Astera Labs in Q2 2026 and held it in 1 quarter.
SLT Holdings's Astera Labs position peaked at $362K in Q2 2026.
519 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.